Literature DB >> 29268400

Lymph node involvement according to lung adenocarcinoma subtypes: lymph node involvement is influenced by lung adenocarcinoma subtypes.

Jae Kil Park1, Jae Jun Kim2, Seok Whan Moon1, Kyo Young Lee3.   

Abstract

BACKGROUNDS: Invasive adenocarcinoma subtypes are known to be associated with prognosis; however, the underlying reason remains unclear. To find out the reason, we investigated the possible influence of lymph node (LN) involvement by the constituent histologic subtypes in the tumor and clarified the different prognosis according to the predominant histologic subtypes in the tumor and LN.
METHODS: A total of 97 consecutive patients who underwent surgical resection for lung invasive adenocarcinoma between February 2009 and December 2015 were included. We analyzed the associations of the histologic subtypes between the tumor and LN and disease-free survival (DFS) according to the histologic subtypes and predicted the histologic subtype in LN involvement using the component ratio of the predominant histologic subtype in the tumor. A P value <0.05 was considered statistically significant.
RESULTS: Acinar and papillary subtypes occupied the majority of the predominant histological subtypes (tumor 73.2%, LN 71.1%). The tumor showed significantly more constituent histologic subtypes than LN (P<0.001). Micropapillary and solid predominant subtype were more common in poorer differentiation (tumor P<0.001, LN P=0.001). The predominant histologic subtype in the tumor was not the same as that in LN and micropapillary and solid predominant subtypes were significantly more prone to LN involvement than other subtypes (P<0.001). Regarding the predominant histologic subtypes in the tumor, there was no significant difference in DFS between micropapillary and solid predominant subtypes and other subtypes. However, regarding the predominant histologic subtypes in LN, micropapillary and solid predominant subtypes had significantly lower DFS than other subtypes (P=0.010). Solid predominant subtype had a significant cutoff value for prediction of the predominant histologic subtype in LN using the component ratio of the predominant histologic subtype in the tumor (cutoff value 12.5%, sensitivity 70.0%, specificity 82.4%, area 0.775, P<0.001).
CONCLUSIONS: The present study presented a possible reason of discrepancies in outcomes according to the lung adenocarcinoma constituent subtypes. Micropapillary and solid predominant subtypes had poorer prognosis than other subtypes, which might be explained by being more prone to LN involvement.

Entities:  

Keywords:  Lung adenocarcinoma; lymph node (LN) metastasis; prognosis

Year:  2017        PMID: 29268400      PMCID: PMC5723791          DOI: 10.21037/jtd.2017.08.132

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  18 in total

Review 1.  Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.

Authors:  Ming-Ching Lee; Kyuichi Kadota; Daniel Buitrago; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Histologic features are important prognostic indicators in early stages lung adenocarcinomas.

Authors:  Joon Yim; Lee-Ching Zhu; Luis Chiriboga; Heather N Watson; Judith D Goldberg; Andre L Moreira
Journal:  Mod Pathol       Date:  2006-12-22       Impact factor: 7.842

3.  Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.

Authors:  Yukinori Sakao; Hideaki Miyamoto; Motoki Sakuraba; Tsumin Oh; Kazu Shiomi; Satoshi Sonobe; Hiroshi Izumi
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

4.  Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.

Authors:  Youngkyu Moon; Kyung Soo Kim; Kyo Young Lee; Sook Whan Sung; Young Kyoon Kim; Jae Kil Park
Journal:  Ann Thorac Surg       Date:  2016-03-05       Impact factor: 4.330

5.  Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung; Wen-Juei Jeng; Teh-Ying Chou; Wen-Hu Hsu; Kou-Juey Wu; Biing-Shiun Huang; Yu-Chung Wu
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

6.  Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.

Authors:  Akihiko Yoshizawa; Shinji Sumiyoshi; Makoto Sonobe; Masashi Kobayashi; Masakazu Fujimoto; Fumi Kawakami; Tatsuaki Tsuruyama; William D Travis; Hiroshi Date; Hironori Haga
Journal:  J Thorac Oncol       Date:  2013-01       Impact factor: 15.609

7.  The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma.

Authors:  Naoki Yanagawa; Satoshi Shiono; Masami Abiko; Shin-ya Ogata; Toru Sato; Gen Tamura
Journal:  Ann Thorac Surg       Date:  2014-06-21       Impact factor: 4.330

8.  Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.

Authors:  Min Jae Cha; Ho Yun Lee; Kyung Soo Lee; Ji Yun Jeong; Joungho Han; Young Mog Shim; Hye Sun Hwang
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-04       Impact factor: 5.209

9.  Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.

Authors:  Hiroyuki Sakurai; Hisao Asamura; Etsuo Miyaoka; Ichiro Yoshino; Yoshitaka Fujii; Yoichi Nakanishi; Kenji Eguchi; Masaki Mori; Noriyoshi Sawabata; Meinoshin Okumura; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2013-05-31       Impact factor: 4.191

10.  Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.

Authors:  Jie Zhang; Jie Wu; Qiang Tan; Lei Zhu; Wen Gao
Journal:  J Thorac Oncol       Date:  2013-09       Impact factor: 15.609

View more
  7 in total

1.  WNT/β-catenin pathway activation via Wnt1 overexpression and Axin1 downregulation correlates with cadherin-catenin complex disruption and increased lymph node involvement in micropapillary-predominant lung adenocarcinoma.

Authors:  Liang Zhu; Shifeng Yang; Linfeng Zheng; Gu Zhang; Guoping Cheng
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

2.  Clinical significance of tumor necrosis and viability in non-small cell lung cancer.

Authors:  Seok Whan Moon; Jae Jun Kim; Seong Cheol Jeong; Yong Hwan Kim; Jung Wook Han
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 3.005

3.  Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.

Authors:  Cheng Chang; Xiaoyan Sun; Wenlu Zhao; Rui Wang; Xiaohua Qian; Bei Lei; Lihua Wang; Liu Liu; Maomei Ruan; Wenhui Xie; Junkang Shen
Journal:  Radiol Med       Date:  2019-12-10       Impact factor: 3.469

4.  Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.

Authors:  Hyun Woo Jeon; Young-Du Kim; Sung Bo Sim; Mi Hyoung Moon
Journal:  Thorac Cancer       Date:  2021-05-25       Impact factor: 3.500

5.  Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.

Authors:  Hyun Woo Jeon; Young-Du Kim; Sung Bo Sim; Mi Hyoung Moon
Journal:  Thorac Cancer       Date:  2021-05-25       Impact factor: 3.500

6.  Cost-Sensitive Uncertainty Hypergraph Learning for Identification of Lymph Node Involvement With CT Imaging.

Authors:  Qianli Ma; Jielong Yan; Jun Zhang; Qiduo Yu; Yue Zhao; Chaoyang Liang; Donglin Di
Journal:  Front Med (Lausanne)       Date:  2022-02-10

7.  The Characteristics and Nomogram for Primary Lung Papillary Adenocarcinoma.

Authors:  Yuqian Zhang; Hui Xie; Ziying Zhang; Pengfei Zhang; Peng Chen; Xiang Wang
Journal:  Open Med (Wars)       Date:  2020-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.